| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,891 |
1,694 |
$105K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
582 |
568 |
$71K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
572 |
558 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
343 |
322 |
$30K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
39 |
38 |
$27K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
249 |
239 |
$20K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
180 |
168 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
546 |
531 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
608 |
575 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
482 |
290 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
64 |
46 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
24 |
24 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
70 |
66 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19 |
19 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
18 |
$2K |
| 85027 |
|
121 |
92 |
$1K |
| 82728 |
|
52 |
38 |
$1K |
| 96127 |
|
174 |
163 |
$998.40 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$959.11 |
| 80061 |
Lipid panel |
13 |
13 |
$869.10 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18 |
18 |
$819.80 |
| 83655 |
|
68 |
53 |
$742.49 |
| 92551 |
|
27 |
26 |
$511.34 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$431.94 |
| 90686 |
|
25 |
25 |
$305.65 |
| 87081 |
|
29 |
26 |
$272.53 |
| 83718 |
|
14 |
14 |
$182.30 |
| 85018 |
|
12 |
12 |
$154.87 |
| 82465 |
|
14 |
14 |
$96.83 |
| 36415 |
Collection of venous blood by venipuncture |
16 |
16 |
$91.44 |